谨防弥漫性大B细胞淋巴瘤中的中性粒细胞/淋巴细胞比值。 - Suppr | 超能文献

Beware of the neutrophil/lymphocyte ratio in diffuse large B-cell lymphoma.

作者信息

Porrata Luis F

机构信息

Mayo Clinic, Rochester, MN, USA.

出版信息

Leuk Lymphoma. 2019 Dec;60(14):3345-3346. doi: 10.1080/10428194.2019.1668940. Epub 2019 Sep 26.

DOI:10.1080/10428194.2019.1668940

Abstract

摘要

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

文档翻译

学术文献翻译模型，支持多种主流文档格式。

相似文献

1

Beware of the neutrophil/lymphocyte ratio in diffuse large B-cell lymphoma.谨防弥漫性大B细胞淋巴瘤中的中性粒细胞/淋巴细胞比值。

Leuk Lymphoma. 2019 Dec;60(14):3345-3346. doi: 10.1080/10428194.2019.1668940. Epub 2019 Sep 26.

2

[Value of Neutrophil/Lymphocyte Ratio and Platelet/Lymphocyte Ratio for Prognostic Evaluation of Diffuse Large B-cell Lymphoma].中性粒细胞/淋巴细胞比值及血小板/淋巴细胞比值对弥漫性大B细胞淋巴瘤预后评估的价值

Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2016 Apr;24(2):427-32. doi: 10.7534/j.issn.1009-2137.2016.02.022.

3

Neutrophil to lymphocyte ratio improves prognostic prediction of International Prognostic Index for patients with diffuse large B-cell lymphoma treated with rituximab, cyclophosphamide, doxorubicin, vincristine and prednisone.中性粒细胞与淋巴细胞比值改善了接受利妥昔单抗、环磷酰胺、阿霉素、长春新碱和泼尼松治疗的弥漫性大B细胞淋巴瘤患者国际预后指数的预后预测。

Leuk Lymphoma. 2015 Jul;56(7):2032-8. doi: 10.3109/10428194.2014.982642. Epub 2015 Jan 21.

4

Prognostic implication of leucocyte subpopulations in diffuse large B-cell lymphoma.弥漫性大B细胞淋巴瘤中白细胞亚群的预后意义

Oncotarget. 2017 Jul 18;8(29):47790-47800. doi: 10.18632/oncotarget.17830.

5

The impact of the neutrophil:lymphocyte ratio in response and survival of patients with de novo diffuse large B-cell lymphoma.中性粒细胞与淋巴细胞比值对初发弥漫性大B细胞淋巴瘤患者缓解情况及生存的影响

Leuk Res. 2018 Apr;67:82-85. doi: 10.1016/j.leukres.2018.02.011. Epub 2018 Feb 19.

6

Lymphocyte-to-monocyte ratio is associated with prognosis of diffuse large B-cell lymphoma: correlation with CD163 positive M2 type tumor-associated macrophages, not PD-1 positive tumor-infiltrating lymphocytes.淋巴细胞与单核细胞比值与弥漫性大B细胞淋巴瘤的预后相关：与CD163阳性M2型肿瘤相关巨噬细胞相关，而非PD-1阳性肿瘤浸润淋巴细胞。

Oncotarget. 2017 Jan 17;8(3):5414-5425. doi: 10.18632/oncotarget.14289.

7

[Prognostic significance of inflammatory indicators for advanced-stage diffuse large B-cell lymphoma].[炎症指标对晚期弥漫性大B细胞淋巴瘤的预后意义]

Zhonghua Yi Xue Za Zhi. 2018 Apr 24;98(16):1250-1255. doi: 10.3760/cma.j.issn.0376-2491.2018.16.013.

8

Predicting survival for diffuse large B-cell lymphoma patients using baseline neutrophil/lymphocyte ratio.基于基线中性粒细胞/淋巴细胞比值预测弥漫性大 B 细胞淋巴瘤患者的生存。

Am J Hematol. 2010 Nov;85(11):896-9. doi: 10.1002/ajh.21849.

9

A new prognostic model using the NCCN-IPI and neutrophil-to-lymphocyte ratio in diffuse large B-cell lymphoma.一种使用NCCN-IPI和中性粒细胞与淋巴细胞比值的弥漫性大B细胞淋巴瘤新预后模型。

Tumori. 2018 Aug;104(4):292-299. doi: 10.5301/tj.5000694. Epub 2018 May 8.

10

An inflammation-based cumulative prognostic score system in patients with diffuse large B cell lymphoma in rituximab era.利妥昔单抗时代弥漫性大 B 细胞淋巴瘤患者基于炎症的累积预后评分系统。

BMC Cancer. 2018 Jan 2;18(1):5. doi: 10.1186/s12885-017-3931-z.

引用本文的文献

1

Tumor interferon signaling and suppressive myeloid cells are associated with CAR T-cell failure in large B-cell lymphoma.肿瘤干扰素信号和抑制性髓系细胞与大 B 细胞淋巴瘤中嵌合抗原受体 T 细胞治疗失败相关。

Blood. 2021 May 13;137(19):2621-2633. doi: 10.1182/blood.2020007445.

2

Improving the international prognostic index score using peripheral blood counts: Results of a large multicenter study involving 520 patients with diffuse large B cell lymphoma.利用外周血细胞计数改善国际预后指数评分：一项涉及 520 例弥漫性大 B 细胞淋巴瘤患者的大型多中心研究结果。

Hematol Oncol. 2020 Oct;38(4):439-445. doi: 10.1002/hon.2757. Epub 2020 Jun 17.